Disc Medicine Announces $100M Proposed Public Offering Of Common Stock And Pre-Funded Warrants
Portfolio Pulse from Benzinga Newsdesk
Disc Medicine (NASDAQ:IRON) has announced a $100 million public offering of common stock and pre-funded warrants. The company plans to use the net proceeds for research, clinical development, working capital, and other general corporate purposes. Morgan Stanley, SVB Securities, Stifel, and BMO Capital Markets are acting as joint book-running managers.
June 12, 2023 | 8:05 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Disc Medicine announces a $100M public offering of common stock and pre-funded warrants, potentially impacting its stock price.
Disc Medicine's announcement of a $100M public offering of common stock and pre-funded warrants may have a short-term impact on its stock price. However, the direction of the impact is uncertain as it depends on market conditions and investor sentiment towards the offering.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100